Insmed INSM
NASDAQ INSM
$111.12 +2.53 (+2.33%)
At close: Oct 2, 2026 · 4:00 PM EDT

Insmed (INSM) Return on Invested Capital [ROIC] (2013 - 2026)

Updated

Insmed (INSM) recorded Return on Invested Capital [ROIC] of -65.98% in Q2 2026, up 1.18 percentage points from -67.16% a year earlier and up 25.19 percentage points from the prior quarter.

Analysis

Insmed (INSM) Return on Invested Capital [ROIC] (2013 - 2026) Analysis & Trends

For FY2025, Insmed reported Return on Invested Capital [ROIC] of -93.44%, down 14.03 percentage points from FY2024.

  • Annual Return on Invested Capital [ROIC] has declined for three straight years, with a five-year change of -50.30 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Invested Capital [ROIC] came in at -79.40% in FY2024 (-9.71 pp), -69.69% in FY2023 (-27.93 pp), -41.76% in FY2022 (+4.67 pp) and -46.42% in FY2021 (-3.29 pp).
  • The Q2 2026 figure is the highest quarterly Return on Invested Capital [ROIC] since Q4 2024.
  • On a year-over-year basis, Return on Invested Capital [ROIC] rose in five of the last eight quarters, with an average year-over-year change of +1.63 percentage points.
  • Peak year-over-year performance for Return on Invested Capital [ROIC] in the last five years was a gain of 22.27 percentage points in Q4 2024, against a drop of 48.08 percentage points in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -91.17% (Q1 2026), -90.17% (Q4 2025) and -70.71% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Insmed 24.26 Bn 18.76 Bn 358.27 Mn -65.98%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -65.98%
Mar 31, 2026 -91.17%
Dec 31, 2025 -90.17%
Sep 30, 2025 -70.71%
Jun 30, 2025 -67.16%
Mar 31, 2025 -75.66%
Dec 31, 2024 -62.13%
Sep 30, 2024 -62.39%
Jun 30, 2024 -79.68%
Mar 31, 2024 -92.91%
Dec 31, 2023 -84.40%
Sep 30, 2023 -74.13%
Jun 30, 2023 -63.99%
Mar 31, 2023 -44.82%
Dec 31, 2022 -46.47%
Sep 30, 2022 -51.16%
Jun 30, 2022 -43.81%
Mar 31, 2022 -40.39%
Dec 31, 2021 -36.63%
Sep 30, 2021 -34.50%
API Access

Insmed Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=INSM&period=max&api_key=YOUR_API_KEY